Yahoo
NSE - Delayed Quote INR

Advanced Enzyme Technologies Limited (ADVENZYMES.NS)

281.45 +17.90 (+6.79%)
At close: November 2 at 3:29:58 PM GMT+5:30
ADVENZYMES.NS Q2 2027 earnings call
Today at 4:00 PM GMT+5:30
Chart Range Bar
Loading chart for ADVENZYMES.NS
  • Previous Close 263.55
  • Open 271.00
  • Bid --
  • Ask --
  • Day's Range 265.65 - 288.00
  • 52 Week Range 246.80 - 419.00
  • Volume 944,092
  • Avg. Volume 265,868
  • Market Cap (intraday) 30.37B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 19.00
  • EPS (TTM) 14.81
  • Earnings Date --
  • Forward Dividend & Yield 1.35 (0.51%)
  • Ex-Dividend Date Jul 24, 2026
  • 1y Target Est 370.00

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers serratiopeptidase, fungal lactase, peptizyme SP, nattokinase, fungal lipase, alpha galactosidase, saccharomyces boulardii, hemicellulose, papain, bromelain, fungal proteases, and bacterial alpha amylase. It also provides probiotics for human and animal nutrition. In addition, the company offers enzymes and probiotics for fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, oils and fats processing, biofuels, and specialty applications. Further, it provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.

www.advancedenzymes.com

409

Full Time Employees

March 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

ADVENZYMES.NS
6.48%
S&P BSE SENSEX (^BSESN)
11.18%

1-Year Return

ADVENZYMES.NS
8.24%
S&P BSE SENSEX (^BSESN)
9.82%

3-Year Return

ADVENZYMES.NS
5.33%
S&P BSE SENSEX (^BSESN)
18.12%

5-Year Return

ADVENZYMES.NS
19.33%
S&P BSE SENSEX (^BSESN)
26.09%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 2.03B
Earnings --
Profit Margin 0.00%

Q1

FY26

Q2

FY26

Q3

FY26

Q4

FY26

0
500M
1B
2B
2B
0.0%
5.0%
10.0%
15.0%
20.0%

Analyst Insights

View More

Analyst Price Targets

370.00
370.00 Average
281.45 Current
370.00 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.84%

  • Return on Assets (ttm)

    6.87%

  • Return on Equity (ttm)

    10.95%

  • Revenue (ttm)

    7.82B

  • Net Income Avi to Common (ttm)

    1.71B

  • Diluted EPS (ttm)

    14.81

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.73B

  • Total Debt/Equity (mrq)

    3.12%

  • Levered Free Cash Flow (ttm)

    513.71M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: